PT  - JOURNAL ARTICLE
AU  - M Chatwin
AU  - G Hawkins
AU  - L Panicchia
AU  - A Woods
AU  - A Hanak
AU  - R Lucas
AU  - E Baker
AU  - E Ramhamdany
AU  - B Mann
AU  - J Riley
AU  - M R Cowie
AU  - A K Simonds
TI  - Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial)
AID  - 10.1136/thoraxjnl-2015-207045
DP  - 2016 Apr 01
TA  - Thorax
PG  - 305--311
VI  - 71
IP  - 4
4099  - http://thorax.bmj.com/content/71/4/305.short
4100  - http://thorax.bmj.com/content/71/4/305.full
SO  - Thorax2016 Apr 01; 71
AB  - Objective To assess the impact of home telemonitoring on health service use and quality of life in patients with severe chronic lung disease.Design Randomised crossover trial with 6 months of standard best practice clinical care (control group) and 6 months with the addition of telemonitoring.Participants 68 patients with chronic lung disease (38 with COPD; 30 with chronic respiratory failure due to other causes), who had a hospital admission for an exacerbation within 6 months of randomisation and either used long-term oxygen therapy or had an arterial oxygen saturation (SpO2) of <90% on air during the previous admission. Individuals received telemonitoring (second-generation system) via broadband link to a hospital-based care team.Outcome measures Primary outcome measure was time to first hospital admission for an acute exacerbation. Secondary outcome measures were hospital admissions, general practitioner (GP) consultations and home visits by nurses, quality of life measured by EuroQol-5D and hospital anxiety and depression (HAD) scale, and self-efficacy score (Stanford).Results Median (IQR) number of days to first admission showed no difference between the two groups—77 (114) telemonitoring, 77.5 (61) control (p=0.189). Hospital admission rate at 6 months increased (0.63 telemonitoring vs 0.32 control p=0.026). Home visits increased during telemonitoring; GP consultations were unchanged. Self-efficacy fell, while HAD depression score improved marginally during telemonitoring.Conclusions Telemonitoring added to standard care did not alter time to next acute hospital admission, increased hospital admissions and home visits overall, and did not improve quality of life in chronic respiratory patients.Trial registration number NCT02180919 (ClinicalTrials.gov).